Scinovex
article Open AccessTop 10% cited

Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition

Michael CharltonAnuradha KrishnanKimberly VikerSchuyler O. SandersonSophie C. CazanaveAndrea L. McConicoHoward MasuokoGregory J. Gores

Abstract

Although there are small animal platforms that recapitulate some of the histological features of nonalcoholic fatty liver disease, there are no small animal models of nonalcoholic steatohepatitis (NASH) with consistent hepatocellular ballooning and progressive fibrosis that also exhibit fidelity to the human condition physiologically. We examined the metabolic and histological effects of a diet on the basis of the composition of "fast food" (high saturated fats, cholesterol, and fructose). Mice (n = 8 in each group) were assigned to diets as follows: 1) standard chow (SC), i.e., 13% energy as fat [1% saturated fatty acids (SFA)], 2) high fat (HF), i.e., 60% energy as fat (1% SFA), and 3) fast food (FF), i.e., 40% energy as fat (12% SFA, 2% cholesterol). All three diets were supplemented with high fructose. All diets produced obesity. The HF and FF diets produced insulin resistance. Liver histology was normal in animals fed the SC diet. Steatohepatitis with pronounced ballooning and progressive fibrosis (stage 2) was observed in mice fed the FF diet. Although the HF diet produced obesity, insulin resistance, and some steatosis; inflammation was minimal, and there was no increase in fibrosis. The FF diet produced a gene expression signature of increased fibrosis, inflammation, and endoplasmic reticulum stress and lipoapoptosis. A diet based on high cholesterol, high saturated fat, and high fructose recapitulates features of the metabolic syndrome and NASH with progressive fibrosis. This represents a novel small animal model of fibrosing NASH with high fidelity to the human condition. These results highlight the contribution of dietary composition to the development of nonalcoholic fatty liver disease and NASH.

Liver Disease Diagnosis and TreatmentDiet, Metabolism, and DiseaseEndoplasmic Reticulum Stress and DiseaseFibrosisInternal medicineInsulin resistanceSteatosisEndocrinologySteatohepatitisMetabolic syndromeNonalcoholic fatty liver diseaseFatty liverBiology

MeSH terms

AnimalsDisease Models, AnimalFatty LiverLiverLiver CirrhosisApoptosisDisease ProgressionMiceUnfolded Protein ResponseDiet, High-FatNon-alcoholic Fatty Liver Disease
Citations
437
FWCI
9.58
field-weighted impact
References
70
Percentile
99%
vs. same field & year
Citations per year
Cited by
Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease
Digestive Diseases and Sciences · 2016 · 676 citations
Mechanisms of NAFLD development and therapeutic strategies
Nature Medicine · 2018 · 4,074 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition · Scinovex